Assessing prevalence and determinants of routine viral load monitoring among pregnant and breastfeeding women on first line antiretroviral therapy at Dedza District Hospital.
Loading...
Date
2021-07-15
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Kamuzu University of Health Sciences
Abstract
Study type: This will be a descriptive quantitative cross-sectional study.
Background
Increased maternal viral load poses a serious health risk of mother to child
transmission of HIV and increased morbidity and mortality to both pregnant and
breastfeeding women. As part of prevention of mother to child transmission of HIV, both
WHO and UNAIDS recommend vial load monitoring to all eligible client on ART at six
months, 12 months and then every 12 months thereafter if the patient is stable on ART.
Viral load monitoring plays a pivotal role in assessing treatment outcome, early detection
of treatment failure and determining treatment failure.
Currently, Malawi is using 4th edition of clinical management of HIV in adults
and children of 2018. This is being used hand in hand with 2019 policy updates
addendum to the 4th edition which came into force from April, 2019. The updated
guidelines on routine monitoring of viral load recommends viral load testing at six
months after starting ART, at 12 months and then every 12 months from the last test if
the patient is stable on ART. This is different from the previous edition that was
recommending routine monitoring of viral load at 6 months, 2years, 4yrs and then every
2years from the previous test.
Problem
Dedza District Hospital is one of the facilities that offers a wide range of ART
and PMTCT services. It is estimated that more than 800 women are enrolled in PMTCT
programme annually. Despite the reported positive progress on the increased number of
pregnant and breastfeeding women enrolled in PMTCT programme at the facility, there is
insufficient evidence suggesting the extent of routine viral load monitoring
implementation and factors influencing it following introduction of 2019 new guidelines.
This therefore calls for urgent need for a research to establish the magnitude of routine
viral load monitoring among PMTCT women. Objectives
The main objective of the study is to assess prevalence and determinants of Viral
Load Monitoring among HIV Positive Pregnant Women on First Line Antiretroviral
Therapy in Dedza District.
The specific objectives include;
To establish social demographic characteristics of HIV positive pregnant and
breastfeeding women receiving PMTCT services at Dedza district hospital
To ascertain the proportion of pregnant and breastfeeding women receiving
routine viral load monitoring.
To determine factors associated with viral load monitoring among pregnant and
breastfeeding women on first line antiretroviral therapy
Methodology
A quantitative cross sectional design will be used on randomly selected master
cards of clients enrolled in PMTCT from April 2019 to April 2020. Data will be collected
using a structured data collection sheet and will be organized on a spread sheet for
cleaning before actual analysis using Statistical Package for the Social Sciences (SPSS)
version 20. Strength of association will be measured using odds ratio and 95%
confidence intervals and the p-value <0.05 will be set for statistical significance.
Expected findings
This study is expected to reveal the prevalence of routine viral load monitoring among pregnant and
breastfeeding women at Dedza district hospital and factors that determine it. Dissemination of results
The results of this study will be disseminated at Kamuzu College of Nursing
Research Conference. Copies will be sent to Dedza District Hospital where study will be
conducted, Kamuzu College of Nursing Library where the researcher is pursuing his studies,
College of Medicine Research Ethics Committee (COMREC) where ethical clearance will
be obtained and all research supervisors who are providing academic support. Relevant
findings of this study will also be sent for possible publication in peer-review journals
through KCN.